BioSpace News Archive

Morphogenesis, Inc. and CohBar, Inc. today announced that Morphogenesis’ abstract has been accepted for poster presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting.

ImmunoPrecise Antibodies Ltd. announced that its subsidiary, BioStrand®, has successfully solved the Information Integration Dilemma by developing a unique technology design that enables their patented HYFT Technology to encapsulate and unify diverse data modalities - including syntactical data, 3D structural data, unstructured scientific information, and beyond - into a singular, integrated framework.

Kiyatec and AstraZeneca Announce a Multifaceted Research Agreement to Generate Novel Preclinical Data Using Kiyatec’s 3D Spheroid Screening Platform, KIYA-Predict TM.

Aprea Therapeutics, Inc. today announced that Oren Gilad, Ph.D., President and Chief Executive Officer, will present a corporate overview at the BIO International Convention, being held in Boston, Massachusetts from June 5-8, 2023.

Rain Oncology Inc., a clinical stage company developing precision oncology therapeutics announced an update to its clinical strategy for milademetan, its small molecule inhibitor of the MDM2-p53 complex, to optimize Company resources.

A2 Biotherapeutics, Inc. today announced the first patient has been dosed in the Phase 1 clinical trial of A2B530.

Allurion, a company dedicated to ending obesity, today announced that it will be participating in the Jefferies Healthcare Conference taking place at the Marriott Marquis, New York, NY on June 7-9, 2023.

ChromaDex Corp. (NASDAQ:CDXC) today announced that it will be participating at the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel, California on June 6th-8th, 2023.

DiaMedica Therapeutics Inc. today announced the appointment of Dr. Richard Kuntz to its Board of Directors effective May 30, 2023.

SciSparc Ltd. announced that as part of its restructuring plans to unlock value for shareholders, it has appointed a new Vice President of Strategy and Business Development, Mr. Yaki Baranes, to structure business strategies and facilitate identifying new business opportunities.